세계의 혈압 측정 커프 시장 : 유형별, 사이즈별, 사용법별, 연령층별, 유통 채널별, 최종 사용자별, 지역별 예측(-2032년)

Blood Pressure Cuffs Market by Type (Automated, Manual), Size, Usage (Reusable, Disposable), Age Group (Adults, Infants & Children), Distribution Channel (Retail, Online), End User (Hospitals, Clinics, Homecare) Region- Global Forecast to 2032

US $ 4,950 ￦ 6,972,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,366,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,479,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,085,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 혈압 측정 커프 시장 규모는 예측 기간 동안 9.0%의 연평균 성장률(CAGR)로 성장할 것으로 전망되고 2025년 7억 달러에서 2032년에는 13억 달러에 이를 것으로 예측됩니다.

조사 범위
조사 대상 연도	2023-2032년
기준 연도	2024년
예측 기간	2025-2030년
검토 단위	금액(10억 달러)
부문	유형별, 사이즈별, 사용법별, 연령층별, 유통 채널별, 최종 사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

고혈압, 비만, 심혈관 질환을 비롯한 만성 비전염성 질병의 세계적 부담이 증가하면서 혈압 모니터링 시장의 확장이 주로 촉진되고 있습니다. 이러한 질환은 혈압 수치를 크게 상승시켜 지속적인 모니터링과 관리가 필요합니다. 또한, 고혈압 및 관련 합병증에 대한 대중과 의료계의 인식이 높아짐에 따라 효과적인 진단 및 모니터링 솔루션에 대한 수요가 증가했습니다. 동시에, 주요 업체들의 지속적인 기술 발전과 제품 혁신이 시장 성장을 더욱 뒷받침하고 있습니다. 이러한 발전에는 정확성, 사용 편의성 및 환자 순응도를 개선하기 위한 비침습적, 자동화 및 웨어러블 혈압 모니터링 장비의 도입이 포함됩니다.

유형별로 혈압 커프 시장은 자동 부문과 수동 부문으로 나뉩니다. 자동 혈압 커프 부문은 2024년에 가장 큰 시장 점유율을 차지했습니다. 자동 혈압 커프는 일상적인 검진 및 24시간 외래 모니터링을 위해 임상 환경에서 널리 사용되며, 지속적이고 정확한 측정값을 제공합니다. 이 기기는 사용자 친화적인 디자인, 디지털 디스플레이, 전문적인 교육 없이도 일관된 측정값을 제공할 수 있는 기능으로 호평을 받고 있습니다. 고령화, 잘못된 식습관, 스트레스 증가로 인해 세계적으로 고혈압의 유병률이 증가하면서 자동 모니터링 솔루션에 대한 수요가 크게 증가했습니다.

용도별로 혈압 커프 시장은 재사용 가능 유형과 일회용 유형으로 나뉩니다. 재사용 가능한 혈압 커프 부문은 2024년에 가장 큰 시장 점유율을 차지했습니다. 이 부문의 큰 점유율은 장치가 자주 사용되는 병원, 요양원, 클리닉과 같은 대규모 의료 시설의 비용 효율성 때문으로 보입니다. 이러한 기관은 일회용 커프에 비해 교체 필요성이 줄어들어 장기적인 비용 절감을 누릴 수 있습니다. 환경 문제의 증가로 의료 폐기물을 최소화하기 위한 노력도 강화되고 있으며, 이는 지속 가능하고 환경 친화적인 의료 관행으로의 전환을 촉진하고 있습니다. 규제 기관과 의료 기관도 재사용 가능한 의료 제품 채택을 장려하는 정책과 지침을 도입하며, 이는 해당 제품의 광범위한 사용을 더욱 지원하고 있습니다.

세계의 혈압 측정 커프 시장은 북미, 유럽, 라틴 아메리카, 아시아태평양, 중동 및 아프리카의 5개 주요 지역으로 나뉩니다. 일본, 인도, 중국, 호주, 한국 등 국가를 포함하는 아시아태평양 지역은 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다. 아시아태평양 지역의 이러한 성장에는 질병의 조기 발견 및 정기 건강 검진을 촉진하는 정부 정책의 강화, 의료비 지출의 증가, 병원 네트워크 및 진단 실험실의 확대 등 여러 요인이 기여하고 있습니다. 또한, 환자의 인식이 높아지고 혈압 모니터링에 대한 인식이 확산되면서 시장 성장이 가속화되고 있습니다.

본 보고서에서는 세계의 혈압 측정 커프 시장에 대해 조사했으며, 유형별, 크기별, 사용법별, 연령층별, 유통채널별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 소개
• 시장 역학
• 업계 동향
• 기술 분석
• Porter's Five Forces 분석
• 규제 상황
• 특허 분석
• 무역 분석
• 가격 분석
• 상환 분석
• 주된 회의 및 이벤트(2025-2026년)
• 주요 이해관계자와 구매 기준
• 미충족 수요/최종 사용자의 기대
• 밸류체인 분석
• 공급망 분석
• AI/생성형 AI가 혈압계 시장에 미치는 영향
• 생태계 분석
• 사례 연구 분석
• 혈압 측정 커프 시장의 인접 시장
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 투자 및 자금조달 시나리오
• 혈압계 시장에의 트럼프 관세의 영향

제6장 혈압 측정 커프 시장(유형별)

• 소개
• 자동
• 수동

제7장 혈압 측정 커프 시장(사이즈별)

• 소개
• 유아-젊은 성인(8-25cm)
• 성인-장년층(26-34cm)
• 대형 성인(35-50 cm)

제8장 혈압 측정 커프 시장(용도별)

• 소개
• 재사용 가능
• 일회용

제9장 혈압 측정 커프 시장(연령층별)

• 소개
• 성인
• 영유아

제10장 혈압 측정 커프 시장(유통 채널별)

• 소개
• 의료시설
• 소매 약국
• 온라인 약국

제11장 혈압 측정 커프 시장(최종 사용자별)

• 소개
• 병원
• 재택 케어
• 외래 진료 센터
• 응급 진료 센터
• 기본 진료 센터
• 기타

제12장 혈압 측정 커프 시장(지역별)

• 소개
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시 경제 전망
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시 경제 전망
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시 경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • GCC 국가
  • 기타

제13장 경쟁 구도

• 개요
• 주요 진입기업의 전략/강점
• 수익 분석, 2022년-2024년
• 시장 점유율 분석(2024년)
• 기업평가 매트릭스 : 주요 진입기업(2024년)
• 기업평가 매트릭스 : 스타트업/중소기업(2024년)
• 기업평가와 재무지표
• 브랜드/제품 비교 분석
• 경쟁 시나리오

제14장 기업 프로파일

• 주요 진출기업
  • OMRON CORPORATION
  • BAXTER INTERNATIONAL, INC.
  • KONINKLIJKE PHILIPS NV
  • GE HEALTHCARE TECHNOLOGIES INC.
  • MCKESSON CORPORATION
  • B. BRAUN MELSUNGEN AG
  • HALMA PLC
  • OSI SYSTEMS, INC.
  • AMERICAN DIAGNOSTIC CORPORATION
  • MEDLINE INDUSTRIES, LP.
  • MICROLIFE CORPORATION
  • BIOS MEDICAL
  • ACCOSON
  • MIDMARK CORPORATION
  • BEURER GMBH
• 기타 기업
  • CELLBIOS
  • SOLARIS MEDICAL TECHNOLOGY, INC.
  • SPENGLER HOLTEX GROUP
  • TECHNICUFF
  • WA BAUM CO., INC.
  • BPL MEDICAL TECHNOLOGIES
  • BOEN HEALTHCARE CO., LTD.
  • MASIMO
  • F. BOSCH MEDIZINTECHNIK
  • MDF INSTRUMENTS

제15장 부록

HBR

영문 목차

영문목차

The global blood pressure cuffs market is projected to reach USD 1.3 billion by 2032 from USD 0.7 billion in 2025, at a CAGR of 9.0% during the forecast period.

Scope of the Report
Years Considered for the Study	2023-2032
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	Type, Size, Usage, Age Group, Distribution Channel, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

The increasing global burden of chronic non-communicable diseases, including hypertension, obesity, and cardiovascular disorders, primarily drives the expansion of the blood pressure monitoring market. These conditions significantly increase blood pressure levels, necessitating consistent monitoring and management. Moreover, heightened public and clinical awareness of hypertension and its associated complications has led to greater demand for effective diagnostic and monitoring solutions. Concurrently, market growth is further supported by continuous technological advancements and product innovation by key industry players. These developments include introducing non-invasive, automated, and wearable blood pressure monitoring devices to improve accuracy, usability, and patient compliance.

By type, the automated segment accounted for the largest market share in 2024.

By type, the blood pressure cuffs market is segmented into automated and manual segments. The automated blood pressure cuffs segment accounted for the largest market share in 2024. The automated blood pressure cuffs are widely used in clinical environments for routine check-ups and 24-hour ambulatory monitoring, providing continuous and accurate readings. These devices are favored for their user-friendly design, digital displays, and ability to deliver consistent measurements without requiring specialized training. The growing prevalence of hypertension worldwide, driven by aging populations, poor dietary habits, and increased stress, has significantly boosted the demand for automated monitoring solutions.

By usage, the reusable segment accounted for the largest market share in 2024.

By usage, the blood pressure cuffs market into reusable and disposable types. The reusable blood pressure cuffs segment accounted for the largest market share in 2024. The large share of this segment is attributed to the cost-effectiveness in large healthcare facilities such as hospitals, nursing homes, and clinics, where devices are used frequently. These institutions benefit from the long-term savings associated with reduced replacement needs compared to single-use cuffs. Growing environmental concerns have also led to increased initiatives to minimize medical waste, encouraging the shift towards sustainable and eco-friendly healthcare practices. Regulatory bodies and healthcare organizations also introduce policies and guidelines that favor adopting reusable medical products, further supporting their widespread use.

By region, the Asia Pacific region is projected to grow at the highest CAGR during the forecast period.

The global blood pressure cuffs market is divided into five key regions: North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. The Asia Pacific region, which includes countries like Japan, India, China, Australia, South Korea, and others, is expected to grow at the highest CAGR during the forecast period. Several factors contribute to this growth in the Asia Pacific, including rising government initiatives promoting early disease detection and routine health screenings, increasing healthcare expenditures, and expanding hospital networks and diagnostic laboratories. Additionally, the growing patient awareness and the awareness of blood pressure monitoring is fueling market growth.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-40%, Tier 2-50%, and Tier 3- 10%
• By Designation: C-level-48%, Director-level-37%, and Others-15%
• By Region: North America-46%, Europe-26%, Asia Pacific-17%, Latin America- 7%, and the Middle East and Africa - 5%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The leading players operating in the blood pressure cuffs market are OMRON Corporation, Inc. (Japan), Baxter International Inc. (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (US), McKesson Corporation. (US), B Braun Melsungen AG (Germany), Halma plc (UK), OSI Systems, Inc. (US), American Diagnostic Corporation (US), Microlife Corporation (Switzerland), BIOS Medical (UK), ACCOSON (UK), Midmark Corporation (US), and Beurer GmbH (Germany).

Research Coverage

This report segments the global blood pressure cuffs market based on various criteria: type (automated and manual), size (infants to young adults (8-25 cm), adults to long adults (26-34cm), large to extra-large adults (35-50cm), usage (reusable and disposable), age group (adults and infants & children), distribution channel (healthcare facilities, retail pharmacies, and online pharmacies), end user (hospitals, homecare settings, ambulatory care centers, urgent care centers, primary centers, and other end users), and region (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa).

The report analyzes the key drivers, challenges, opportunities, and restraints influencing market growth. It also offers a detailed evaluation of leading industry players, covering their business profiles, service portfolios, strategic initiatives, partnerships, acquisitions, and recent blood pressure cuffs market developments. Furthermore, the report explores the competitive dynamics of emerging startups within the blood pressure cuffs ecosystem.

Reasons to Buy the Report

The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:

• Analysis of key drivers (increasing geriatric population and subsequent increase in CVD and hypertension, high incidence of HAIs to fuel adoption of single-use pressure cuffs), restraints (availability of alternative methods and devices for monitoring blood pressure), opportunities (rising technological advancements in blood pressure monitors, growing demand for telehealth & remote patient monitoring services), and challenges (miscuffing challenges, technical limitations, and accuracy issues, issues with manual errors, low awareness regarding hypertension)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the blood pressure cuffs market
• Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the blood pressure cuffs market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the blood pressure cuffs market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies & primary interviews
    • 2.2.1.3 Approach 3: Primary interviews
    • 2.2.1.4 Approach 4: Growth Forecast
    • 2.2.1.5 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 STUDY-RELATED ASSUMPTIONS
  • 2.4.2 GROWTH RATE ASSUMPTIONS
• 2.5 RISK ASSESSMENT
• 2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 BLOOD PRESSURE CUFFS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: BLOOD PRESSURE CUFFS MARKET, BY TYPE & COUNTRY (2024)
• 4.3 BLOOD PRESSURE CUFFS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 BLOOD PRESSURE CUFFS MARKET: REGIONAL MIX (2025-2032)
• 4.5 BLOOD PRESSURE CUFFS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing geriatric population and subsequent rise in CVD and hypertension
    • 5.2.1.2 High incidence of HAIs to fuel adoption of single-use pressure cuffs
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Availability of alternative methods & devices for monitoring blood pressure
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising technological advancements in blood pressure monitors
    • 5.2.3.2 Growing demand for telehealth & remote patient monitoring services
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Miscuffing challenges
    • 5.2.4.2 Technical limitations and accuracy issues
    • 5.2.4.3 Issues with manual errors
    • 5.2.4.4 Low awareness regarding hypertension
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ADOPTION OF REUSABLE BLOOD PRESSURE CUFFS FOR INFECTION CONTROL MEASURES
  • 5.3.2 ADVANCEMENTS IN WEARABLE BLOOD PRESSURE MONITORING DEVICES
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Oscillometry
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Auscultatory techniques
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 Palpatory technique
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5.2 BARGAINING POWER OF SUPPLIERS
  • 5.5.3 BARGAINING POWER OF BUYERS
  • 5.5.4 THREAT OF NEW ENTRANTS
  • 5.5.5 THREAT OF SUBSTITUTES
• 5.6 REGULATORY LANDSCAPE
  • 5.6.1 REGULATORY ANALYSIS
    • 5.6.1.1 North America
      • 5.6.1.1.1 US
      • 5.6.1.1.2 Canada
    • 5.6.1.2 Europe
      • 5.6.1.2.1 Germany
      • 5.6.1.2.2 UK
    • 5.6.1.3 Asia Pacific
      • 5.6.1.3.1 China
      • 5.6.1.3.2 Japan
      • 5.6.1.3.3 India
    • 5.6.1.4 Australia
    • 5.6.1.5 Latin America
    • 5.6.1.6 Middle East
  • 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.6.2.1 North America
    • 5.6.2.2 Europe
    • 5.6.2.3 Asia Pacific
    • 5.6.2.4 Latin America
    • 5.6.2.5 Rest of the World
• 5.7 PATENT ANALYSIS
• 5.8 TRADE ANALYSIS
  • 5.8.1 IMPORT DATA (HS CODE 901890)
  • 5.8.2 EXPORT DATA (HS CODE 901890)
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE TREND, BY TYPE, 2023-2025
  • 5.9.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
  • 5.9.3 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025
• 5.10 REIMBURSEMENT ANALYSIS
• 5.11 KEY CONFERENCES & EVENTS, 2025-2026
• 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 BUYING CRITERIA
• 5.13 UNMET NEEDS/END-USER EXPECTATIONS
• 5.14 VALUE CHAIN ANALYSIS
• 5.15 SUPPLY CHAIN ANALYSIS
• 5.16 IMPACT OF AI/GENERATIVE AI ON BLOOD PRESSURE CUFFS MARKET
  • 5.16.1 INTRODUCTION
  • 5.16.2 MARKET POTENTIAL OF AI ON BLOOD PRESSURE CUFFS MARKET
  • 5.16.3 AI USE CASES
  • 5.16.4 KEY COMPANIES IMPLEMENTING AI
  • 5.16.5 FUTURE OF AI IN BLOOD PRESSURE CUFFS MARKET
• 5.17 ECOSYSTEM ANALYSIS
• 5.18 CASE STUDY ANALYSIS
  • 5.18.1 CASE STUDY 1: EFFECTS OF CUFF SIZE ON ACCURACY OF BLOOD PRESSURE READINGS
  • 5.18.2 CASE STUDY 2: BLOOD PRESSURE CUFFS COLONIZED BY BACTERIAL DIVERSITY
  • 5.18.3 CASE STUDY 3: IMPLEMENTATION OF REMOTE MONITORING PROTOCOL FOR HIGH-RISK PATIENTS
• 5.19 ADJACENT MARKETS FOR BLOOD PRESSURE CUFFS MARKET
• 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.21 INVESTMENT & FUNDING SCENARIO
• 5.22 TRUMP TARIFF IMPACT ON BLOOD PRESSURE CUFFS MARKET
  • 5.22.1 INTRODUCTION
  • 5.22.2 KEY TARIFF RATES
  • 5.22.3 PRICE IMPACT ANALYSIS
  • 5.22.4 KEY IMPACTS ON COUNTRY/REGION
    • 5.22.4.1 North America
    • 5.22.4.2 Europe
    • 5.22.4.3 Asia Pacific
  • 5.22.5 IMPACT ON END-USE INDUSTRIES
    • 5.22.5.1 Hospitals & ASCs

6 BLOOD PRESSURE CUFFS MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 AUTOMATED BLOOD PRESSURE CUFFS
  • 6.2.1 RISING TECHNOLOGICAL ADVANCEMENTS AND CONVENIENCE IN OUTPATIENT SETTINGS TO BOOST DEMAND
• 6.3 MANUAL BLOOD PRESSURE CUFFS
  • 6.3.1 STANDARD ACCESSIBILITY ACROSS HEALTHCARE FACILITIES TO SUSTAIN MARKET GROWTH

7 BLOOD PRESSURE CUFFS MARKET, BY SIZE

• 7.1 INTRODUCTION
• 7.2 INFANTS TO YOUNG ADULTS (8-25CM)
  • 7.2.1 INCREASING PREVALENCE OF NEONATAL DISORDERS TO FUEL UPTAKE
• 7.3 ADULTS TO LONG ADULTS (26-34 CM)
  • 7.3.1 RISING INCIDENCE OF HYPERTENSION AND GROWING FOCUS ON PATIENT MONITORING TO DRIVE MARKET
• 7.4 LARGE TO EXTRA-LARGE ADULTS (35-50 CM)
  • 7.4.1 INCREASING CASES OF OBESITY AND CVD TO SUPPORT MARKET GROWTH

8 BLOOD PRESSURE CUFFS MARKET, BY USAGE

• 8.1 INTRODUCTION
• 8.2 REUSABLE BLOOD PRESSURE CUFFS
  • 8.2.1 LOW COST AND HIGH DURABILITY TO BOOST DEMAND
• 8.3 DISPOSABLE BLOOD PRESSURE CUFFS
  • 8.3.1 GROWING NEED TO REDUCE TRANSMISSION OF HAIS TO FUEL UPTAKE

9 BLOOD PRESSURE CUFFS MARKET, BY AGE GROUP

• 9.1 INTRODUCTION
• 9.2 ADULTS
  • 9.2.1 GROWING FOCUS ON EARLY DISEASE DIAGNOSIS TO PROPEL MARKET
• 9.3 INFANTS & CHILDREN
  • 9.3.1 INCREASING CASES OF NEONATAL HYPERTENSION TO BOOST DEMAND

10 BLOOD PRESSURE CUFFS MARKET, BY DISTRIBUTION CHANNEL

• 10.1 INTRODUCTION
• 10.2 HEALTHCARE FACILITIES
  • 10.2.1 HIGH PROCUREMENT ACROSS HEALTH AGENCIES TO BOOST DEMAND
• 10.3 RETAIL PHARMACIES
  • 10.3.1 GROWING ACCESSIBILITY IN UNDERSERVED AREAS TO AID MARKET
• 10.4 ONLINE PHARMACIES
  • 10.4.1 LOW COSTS AND REMOTE CONVENIENCE TO PROPEL MARKET

11 BLOOD PRESSURE CUFFS MARKET, BY END USER

• 11.1 INTRODUCTION
• 11.2 HOSPITALS
  • 11.2.1 HIGH PURCHASING POWER FOR INSTALLATION & MAINTENANCE COSTS TO PROPEL MARKET
• 11.3 HOME CARE SETTINGS
  • 11.3.1 GROWING ACCESSIBILITY TO ADVANCED DEVICES OUTSIDE CLINICAL SETTINGS TO DRIVE MARKET
• 11.4 AMBULATORY CARE CENTERS
  • 11.4.1 COST-EFFICIENT OUTPATIENT INFRASTRUCTURE TO BOOST DEMAND
• 11.5 URGENT CARE CENTERS
  • 11.5.1 EXPANDING ACCESS TO CRITICAL CARE TO SUPPORT MARKET GROWTH
• 11.6 PRIMARY CENTERS
  • 11.6.1 GROWING FOCUS ON CHRONIC DISEASE MANAGEMENT TO FUEL UPTAKE
• 11.7 OTHER END USERS

12 BLOOD PRESSURE CUFFS MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.2.2 US
    • 12.2.2.1 High healthcare expenditure and adoption of technologically advanced devices to fuel uptake
  • 12.2.3 CANADA
    • 12.2.3.1 Rising cases of obesity & CVD to drive market
• 12.3 EUROPE
  • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 12.3.2 GERMANY
    • 12.3.2.1 Established healthcare system and stringent regulations for medical devices industry to fuel market
  • 12.3.3 UK
    • 12.3.3.1 Favorable public-private investments in healthcare technologies to aid market
  • 12.3.4 FRANCE
    • 12.3.4.1 Increasing demand for age-monitoring healthcare solutions to fuel market
  • 12.3.5 ITALY
    • 12.3.5.1 Rising cases of CVD to support market growth
  • 12.3.6 SPAIN
    • 12.3.6.1 Growing demand for improved diagnostic accuracy to fuel uptake
  • 12.3.7 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 12.4.2 JAPAN
    • 12.4.2.1 Expanding geriatric population and subsequent rise in chronic diseases to propel market
  • 12.4.3 CHINA
    • 12.4.3.1 Rising establishment of hospitals and surge in infectious diseases to drive market
  • 12.4.4 INDIA
    • 12.4.4.1 Infrastructural improvements and increasing incidence of target conditions to fuel market
  • 12.4.5 AUSTRALIA
    • 12.4.5.1 Expanding healthcare facilities and increasing prevalence of hypertension to boost demand
  • 12.4.6 SOUTH KOREA
    • 12.4.6.1 High adoption of technological advancements in monitoring devices to support market growth
  • 12.4.7 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 12.5.2 BRAZIL
    • 12.5.2.1 Shortage of healthcare professionals and growing focus on remote patient monitoring to drive market
  • 12.5.3 MEXICO
    • 12.5.3.1 High mortality rate for CVD to boost demand
  • 12.5.4 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 GCC COUNTRIES
    • 12.6.1.1 Kingdom of Saudi Arabia (KSA)
      • 12.6.1.1.1 Rising focus on technological innovation to support market growth
    • 12.6.1.2 United Arab Emirates (UAE)
      • 12.6.1.2.1 Promotion of telemedicine to fuel uptake
    • 12.6.1.3 Other GCC Countries
  • 12.6.2 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 13.3 REVENUE ANALYSIS, 2022-2024
• 13.4 MARKET SHARE ANALYSIS, 2024
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Region footprint
    • 13.5.5.3 Usage footprint
    • 13.5.5.4 Age-group footprint
    • 13.5.5.5 End-user footprint
• 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 13.6.5.1 List of key startups/SMEs
• 13.7 COMPANY VALUATION & FINANCIAL METRICS
  • 13.7.1 FINANCIAL METRICS
  • 13.7.2 COMPANY VALUATION
• 13.8 BRAND/PRODUCT COMPARISON ANALYSIS
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 DEALS
  • 13.9.2 EXPANSIONS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 OMRON CORPORATION
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Deals
      • 14.1.1.3.2 Expansions
      • 14.1.1.3.3 Other developments
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Key strengths
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses & competitive threats
  • 14.1.2 BAXTER INTERNATIONAL, INC.
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Expansions
      • 14.1.2.3.2 Other developments
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Key strengths
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses & competitive threats
  • 14.1.3 KONINKLIJKE PHILIPS N.V.
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 MnM view
      • 14.1.3.3.1 Key strengths
      • 14.1.3.3.2 Strategic choices
      • 14.1.3.3.3 Weaknesses & competitive threats
  • 14.1.4 GE HEALTHCARE TECHNOLOGIES INC.
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Deals
  • 14.1.5 MCKESSON CORPORATION
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Other developments
  • 14.1.6 B. BRAUN MELSUNGEN AG
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
  • 14.1.7 HALMA PLC
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Expansions
  • 14.1.8 OSI SYSTEMS, INC.
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products offered
  • 14.1.9 AMERICAN DIAGNOSTIC CORPORATION
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products offered
  • 14.1.10 MEDLINE INDUSTRIES, LP.
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Expansions
  • 14.1.11 MICROLIFE CORPORATION
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products offered
  • 14.1.12 BIOS MEDICAL
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products offered
  • 14.1.13 ACCOSON
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products offered
  • 14.1.14 MIDMARK CORPORATION
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products offered
  • 14.1.15 BEURER GMBH
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products offered
• 14.2 OTHER PLAYERS
  • 14.2.1 CELLBIOS
  • 14.2.2 SOLARIS MEDICAL TECHNOLOGY, INC.
  • 14.2.3 SPENGLER HOLTEX GROUP
  • 14.2.4 TECHNICUFF
  • 14.2.5 W.A. BAUM CO., INC.
  • 14.2.6 BPL MEDICAL TECHNOLOGIES
  • 14.2.7 BOEN HEALTHCARE CO., LTD.
  • 14.2.8 MASIMO
  • 14.2.9 F. BOSCH MEDIZINTECHNIK
  • 14.2.10 MDF INSTRUMENTS

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS

관련자료